Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JINGDONG SU

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1669607479
CMS profile
1380814
Location
TYLER, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$2,900.96

100 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,805.96 99
Education $95.00 1

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 2; records 51–100 of 100 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JINGDONG SU

NPI 1669607479 · CMS profile ID 1380814

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

TYLER, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–100 of 100 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1669607479?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JINGDONG SU, NPI 1669607479, CMS profile ID 1380814. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–100 of 100 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1669607479?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). JINGDONG SU, NPI 1669607479, CMS profile ID 1380814. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–100 of 100 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1669607479?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
JINGDONG SU, NPI 1669607479, CMS profile ID 1380814, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–100 of 100 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1669607479?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

100 matching records · $2,900.96 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 100 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 100.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Daiichi Sankyo Inc. $26.5208/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089487534 CMS
E.R. Squibb & Sons, L.L.C. $14.5308/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101426706 CMS
Tempus AI, Inc $10.3807/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150175252 CMS
Blueprint Medicines Corporation $16.7907/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147449488 CMS
Tempus AI, Inc $64.8807/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150175250 CMS
ADC Therapeutics America, Inc. $18.4507/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1121193529 CMS
Ipsen Biopharmaceuticals, Inc $29.0507/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1091963449 CMS
E.R. Squibb & Sons, L.L.C. $20.1907/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101426704 CMS
Tempus AI, Inc $19.4307/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150175248 CMS
Tempus AI, Inc $29.8407/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150175246 CMS
AstraZeneca Pharmaceuticals LP $23.2806/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104546472 CMS
Tempus AI, Inc $5.9006/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150175244 CMS
Pharmacosmos Therapeutics Inc. $101.7806/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154826411 CMS
Novartis Pharmaceuticals Corporation $16.1906/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087161443 CMS
E.R. Squibb & Sons, L.L.C. $10.4606/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101426692 CMS
E.R. Squibb & Sons, L.L.C. $0.5306/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101426694 CMS
Karyopharm Therapeutics Inc. $13.8706/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145531403 CMS
Tempus AI, Inc $2.9105/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150175242 CMS
Stemline Therapeutics Inc. $26.4705/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142960815 CMS
AstraZeneca Pharmaceuticals LP $26.3205/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105624339 CMS
Tempus AI, Inc $29.2505/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150175240 CMS
ABBVIE INC. $15.1105/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106176995 CMS
E.R. Squibb & Sons, L.L.C. $6.5605/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101426690 CMS
GENZYME CORPORATION $25.0205/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139953096 CMS
Ipsen Biopharmaceuticals, Inc $16.0505/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1091963451 CMS
Janssen Biotech, Inc. $39.1305/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078773365 CMS
Janssen Biotech, Inc. $89.9904/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078773634 CMS
E.R. Squibb & Sons, L.L.C. $16.9904/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101426688 CMS
AstraZeneca Pharmaceuticals LP $124.8304/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104307384 CMS
Tempus AI, Inc $6.3904/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150175236 CMS
Tempus AI, Inc $3.6104/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150175238 CMS
Lilly USA, LLC $14.3304/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135067051 CMS
ABBVIE INC. $23.2504/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106176993 CMS
GENZYME CORPORATION $26.5404/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139953088 CMS
Alexion Pharmaceuticals, Inc. $26.7904/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093923857 CMS
GlaxoSmithKline, LLC. $28.7903/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116305161 CMS
EMD Serono, Inc. $122.1503/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120234820 CMS
AstraZeneca Pharmaceuticals LP $122.1503/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104680131 CMS
GlaxoSmithKline, LLC. $19.2003/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1115890450 CMS
E.R. Squibb & Sons, L.L.C. $10.9603/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101426682 CMS
GENZYME CORPORATION $27.1703/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139953074 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.9902/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086180272 CMS
E.R. Squibb & Sons, L.L.C. $12.5202/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101426680 CMS
Genmab U.S., Inc. $19.4702/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126827766 CMS
E.R. Squibb & Sons, L.L.C. $9.5002/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101426672 CMS
Daiichi Sankyo Inc. $27.4001/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089487514 CMS
E.R. Squibb & Sons, L.L.C. $12.4301/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101426664 CMS
ABBVIE INC. $12.1501/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106176991 CMS
Astellas Pharma US Inc $17.7701/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139291316 CMS
BeiGene USA, Inc. $20.6901/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120867540 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,521.53 42
PY2020 $262.89 5
PY2021 $80.63 5
PY2022 $468.88 13
PY2023 $2,100.29 52
PY2024 $2,900.96 100
PY2025 $3,150.96 100

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $2,081.00 2
PY2023 Principal investigator $38,664.20 25

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

2 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Mirati Therapeutics, Inc. $1,125.00 02/21/2024 Non-covered Recipient Entity
Us Oncology Res Llc
A Randomized Phase 3 Study of Sitravatinib in Combination With Nivolumab Versus Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy S No dispute reported 06/30/2026 1124763962
Principal investigator 1 Mirati Therapeutics, Inc. $956.00 01/15/2024 Non-covered Recipient Entity
Texas Onco Southwest Fort Worth
A Randomized Phase 3 Study of Sitravatinib in Combination With Nivolumab Versus Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy S No dispute reported 06/30/2026 1124763994